ClinConnect ClinConnect Logo
Search / Trial NCT06583005

Vibrotactile Coordinated Reset for Parkinsons Patients Who Are on Dopaminergic Medication

Launched by STANFORD UNIVERSITY · Aug 31, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Vibrotactile Vibrotactile Coordinated Reset Parkinsons Disease

ClinConnect Summary

This clinical trial is looking at a new way to help people with Parkinson's Disease improve their movement and manage their symptoms. It uses a method called vibrotactile coordinated reset stimulation, which involves gentle vibrations to help the brain and body work better together. The study is for adults aged 18 and older who have moderate to advanced Parkinson's symptoms and are currently taking medication for their condition. Participants must be comfortable using technology, like computers and video calls, and must live in the United States.

If you choose to participate, you will be involved for five years and will have a total of five study visits. During these visits, the researchers will monitor your progress and provide training on how to use the stimulation device. It's important to note that you cannot join if you have certain mental health issues, are currently abusing drugs or alcohol, or are pregnant or breastfeeding. This study aims to find out if this new treatment can help people with Parkinson's feel better and move more easily while continuing their regular medications.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Age at the time of enrollment: Adults 18 and older
  • Idiopathic Parkinson's Symptoms between Hoehn and Yahr stages 2 to 4
  • Fluent in English
  • Comfortable with technology; can use a computer, check email, and access the internet; can initiate and engage in a virtual meeting for training and monitoring purposes.
  • Lives in the United States
  • Exclusion Criteria:
  • Any significant neuro-psychiatric problems, including acute confusional state, ongoing psychosis, or suicidal tendencies.
  • Any current drug or alcohol abuse.
  • Participation in another drug, device, or biologics trial concurrently or within the preceding 30 days. Any other trial participation should be approved by the Principal Investigators.
  • Pregnancy, breast-feeding or wanting to become pregnant.
  • Patient is unable to communicate properly with staff (i.e., severe speech problems).
  • Excessive drooling

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported